Trius Therapeutics Company

Trius Therapeutics is focused on the development of innovative antibiotics for life-threatening infections.
Technology: Small Molecules
Industry: PharmTech
Headquarters: Lexington, Massachusetts, United States
Founded Date: 2004
Employees Number: 1001-5000
Funding Status: M&A
Estimated Revenue: $10M to $50M

Visit Website
https://www.twitter.com/cubistbiopharma
Register and Claim Ownership